Market Cap | ₹3,951Cr |
ROE | 22.29% |
P/E Ratio(TTM) | 21.62 |
EPS(TTM) | 110.51 |
P/B Ratio | 7.45 |
Dividend Yield | 1.00% |
Industry P/E | 41.14 |
Book Value | 320.78 |
Debt to Equity | 0.00 |
Face Value | 8 |
Parent Organisation | RPG Life Sciences Limited |
Managing Director | Mr. Yugal Sikri |
NSE Symbol | RPGLIFE |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 103.18 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.33 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.60 | ||
Wockhardt | NA (0.00%) | -195.86 |